Serum lipid and apolipoprotein profiles in newborns and six‐year‐old children: The Tallinn Young Family Study

References

• Enos W., Holmes R., Beyer J. Coronary disease among United States soldiers killed in action in Korea. JAMA 1953; 152: 1090–3
   PubMed Web of Science ®Google Scholar
• McNamara J. J., Molot M. D., Stremple J. F., Cutting R. T. Coronary artery disease in combat casualties in Vietnam. JAMA 1971; 216: 1185–7
   PubMed Web of Science ®Google Scholar
• Yla‐Herttuala S. Biochemistry of the arterial wall in developing atherosclerosis. Ann NY Acad Sci 1991; 623: 40–59
   PubMed Web of Science ®Google Scholar
• Freedman D. S., Byers T., Sell K., Kuester S., Nevell E., Lee S. Tracking of serum cholesterol levels in a multiracial sample of preschool children. Pediatrics 1992; 90: 80–6
   PubMed Web of Science ®Google Scholar
• Kallio M. J. T., Salmenpera L., Siimes M. A., Perheentupa J., Miettinen T. A. Tracking of serum cholesterol and lipoprotein levels from the first year of life. Pediatrics 1993; 91: 949–54
   PubMed Web of Science ®Google Scholar
• Newman W. P., Freedman D. S., Voors A. W., Gard P. D., Srinivasan S. R., Cresenta J. L., et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa Heart Study. N Engl J Med 1986; 314: 138–44
   PubMed Web of Science ®Google Scholar
• PDAY Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking: a preliminary report from the pathobiological determinants of atherosclerosis in youth (PDAY) research group. JAMA 1990; 264: 3018–24
   PubMed Web of Science ®Google Scholar
• Klag M. J., Ford D. E., Mead L. A., HE J., Whelton P. K., Liang K. ‐. Y., et al. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med 1993; 328: 313–8
   PubMed Web of Science ®Google Scholar
• Freedman D. S., Shear C. L., Srinivasan S. R., Webber L. S., Berenson G. S. Tracking serum lipids and apolipoproteins in children over an 8‐year period: the Bogalusa Heart Study. Prev Med 1985; 14: 203–16
   PubMed Web of Science ®Google Scholar
• Lauer R. M., Lee J., Clarke W. R. Factors affecting the relationship between childhood and adult cholesterol levels. The Muscatine Study. Pediatrics 1988; 82: 309–18
   PubMed Web of Science ®Google Scholar
• Stuhldreher W. L., Orchard T. J., Donahue R. P., Kuller L. H., Gloninger M. F., Drash A. L. Cholesterol screening in childhood sixteen‐year Beaver County Lipid Study experience. J Pediatr 1991; 119: 551–6
   PubMedGoogle Scholar
• Raitakari O. T., Porkka K. V., Viikari J. S., Ronnemaa T., Akerblom H. K. Clustering of risk factors for coronary heart disease in children and adolescents. The cardiovascular risk in young Finns study. Acta Paediatr 1994; 83: 936–40
   Google Scholar
• Laskarzeski P., Morrison J., deGroot I., Kelly K., Mellies M. J., Khoury P., et al. Lipid and lipoprotein tracking in 108 children over a four‐year period. Pediatrics 1979; 64: 584–91
   PubMedGoogle Scholar
• Webber L. S., Srinivasan S. R., Wattingney W. A., Berenson G. S. Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalusa Heart Study. Am J Epidemiol 1991; 133: 884–99
   PubMed Web of Science ®Google Scholar
• Porkka K. V., Viikari J. S. Tracking of serum lipids in children: association with the absolute lipid level: the cardiovascular risk in young Finns study. J Clin Epidemiol 1995; 48: 221–8
   PubMed Web of Science ®Google Scholar
• Srinivasan S. R., Berenson G. S. Childhood lipoprotein profiles and implications for adult coronary artery disease: the Bogalusa Heart Study. Am J Med Sci 1995; 310: 62–7
   Google Scholar
• Bao W., Srinivasan S. R., Wattingney W. A., Bao W., Berenson G. S. Usefulness of chilhood low‐density lipoprotein cholesterol level in predicting adult dyslipidemia and other cardiovascular risks. The Bogalusa Heart Study. Arch Intern Med 1996; 156: 1315–20
   PubMedGoogle Scholar
• Niclas T. A., von Duvillard S. P., Berenson G. S. Tracking of serum lipids and lipoproteins from childhood to dyslipidemia in adults: the Bogalusa Heart Study. Int J Sports Med 2002; Suppl 1: S39–43
   Google Scholar
• Sporik R., Johnstone J. H., Cogsvell J. J. Longitudinal study of cholesterol values in 68 children from birth to 11 years of age. Arch Dis Child 1991; 66: 134–7
   PubMedGoogle Scholar
• Bastida S., Sanchez‐Muniz F. J., Cuena R., Perea S., Aragones A. High density lipoprotein‐cholesterol changes in children with high cholesterol levels at birth. Eur J Pediatr 2002; 161: 94–8
   PubMedGoogle Scholar
• Kostner G. M., Avogaro P., Gazzolato G., Marth E., Bittolo‐Bon G., Quinci G. B. Lipoprotein (a) and the risk of myocardial infarction. Atherosclerosis 1981; 38: 51–61
   PubMed Web of Science ®Google Scholar
• Dahlen G. M., Guyton J. R., Attar M., Farmer J. A., Kautz J. A., Gotto A. M. Association of levels of lipoprotein (a), plasma lipids and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986; 74: 758–65
   PubMed Web of Science ®Google Scholar
• Rosengren A., Wilhelmsen L., Eriksson E., Risberg B., Wedel H. Lipoprotein (a) and coronary heart disease: a prospective case‐control study in a general population sample of middle‐aged men. Br Med J 1990; 301: 1248–51
   PubMed Web of Science ®Google Scholar
• Jauhiainen M., Koskinen P., Ehnholm C., Frick M. H., Mänttäri M., Manninen V., et al. Lipoprotein (a) and coronary heart disease risk, a nested case‐control study of the Helsinki Heart Study participants. Atherosclerosis 1991; 89: 59–67
   PubMed Web of Science ®Google Scholar
• Ridker P. M., Hennekens C. H., Stampfer M. J. A prospective study of lipoprotein (a) and risk of future myocardial infarction. J Am Med Assoc 1993; 270: 2195–9
   PubMed Web of Science ®Google Scholar
• Boerwinkle E., Leffert C. C., Lin J., Lacner C., Chiesa G., Hobbs H. H. Apolipoprotein (a) gene accounts for greater than 90% of the variation in plasma lipoprotein (a) concentrations. J Clin Invest 1992; 90: 52–60
   PubMed Web of Science ®Google Scholar
• Czinner A., Bihari V. ‐. M., Gruber E. Racial (gipsy/white) difference in serum Lp(a) levels and its relation to familial risk for atherosclerosis. Atherosclerosis 1994; 109: 286
   Google Scholar
• Vella J. C., Calmarza P., Goni M., Berzoza J. Lipoprotein(a) and other lipidic parameters in newborns from Burgos, Spain. Atherosclerosis 1997; 134: 384
   Google Scholar
• Weisgraber K. H., Rall S. C., Mahley R. W. Human E apolipoprotein heterogeneity: cysteine‐arginine interchanges in the amino acid sequence of the the apo E isoforms. J Biol Chem 1981; 256: 9077–83
   PubMed Web of Science ®Google Scholar
• Srinivasan S. R., Ehnholm C., Wattingly W. A., Bao W., Berenson G. The relation of apolipoprotein E polymorphism to multiple cardiovascular risk in children; the Bogalusa Heart Study. Atherosclerosis 1996; 123: 33–42
   PubMedGoogle Scholar
• Kallio M. J., Salmenpera L., Siimes M. A., Perheentupa J., Gylling H., Miettinen T. A. The apolipoprotein E phenotype has a strong influence on tracking of serum cholesterol and lipoprotein levels in children: a follow‐up study from birth to the age of 11 years. Pediatr Res 1998; 43: 381–5
   PubMedGoogle Scholar
• Aasvee K., Jauhiainen M., Kurvinen E., Jordania R., Sundvall J., Ehnholm C. Lipoprotein(a), apolipopotein A‐I and B serum levels in young families from Tallinn, Estonia. Relationships with other cardiovascular risk factors and nationality. Scand J Clin Lab Invest 1999; 59: 179–90
   PubMed Web of Science ®Google Scholar
• Aasvee K., Kurvinen E., Jordania R., Jauhiainen M., Sundvall J. Lipoprotein parameters in relation to other risk factors of atherosclerosis in adults and newborns: Tallinn Young Family Study. Scand J Clin Lab Invest 2004; 64: 245–54
   PubMed Web of Science ®Google Scholar
• Food and Nutrition III: Manual of Tallinn Technical University. TTU Press, Tallinn 1997, ISBN 9985‐59‐037‐6
   Google Scholar
• Rastas M., Seppänen R., Khuts L. R. Ruoka‐aineden ravintoainesisälto. Kansaneläkelaitos, Helsinki 1990
   Google Scholar
• Kostner G. M., Avogaro P., Bittolo Bon G., Cazzolato G., Quinci G. B. Determination of high‐density lipoproteins: screening methods compared. Clin Chem 1979; 25: 939–42
   PubMed Web of Science ®Google Scholar
• Friedewald W. T., Levy R. J., Fredrickson D. S. Estimation of the concentration of low‐density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Sundvall J., Sulonen G. T. B., Hiltunen O., Kiuru J., Pursiainen M., Jauhiainen M. Comparison a new immunoturbidimetric assay of human serum lipoprotein (a) to the ELISA and the IRMA methods. Scand J Clin Lab Invest 1995; 55: 171–80
   PubMed Web of Science ®Google Scholar
• Riepponen P., Marniemi J., Rautaoja T. Immunoturbidimetric determination of apolipoproteins A‐I and B in serum. Scand J Clin Lab Invest 1987; 47: 739–44
   PubMed Web of Science ®Google Scholar
• Havekes L. M., De Knijff P., Beisiegel U., Havinga J., Smit M., Klasen E. A rapid micromethod for apolipoprotein E phenotyping directly in serum. J Lipid Res 1987; 28: 455–63
   PubMed Web of Science ®Google Scholar
• MedCalc for Windows. Statistics for Biochemical Research. Frank Schoonjans, Belgium 1993–999, Copyright ©
   Google Scholar
• Van Biervliet J. P., Labeur C., Michiels G., Usher D. S., Rosseneu M. Lipoprotein (a) profiles and evolution in newborns. Atherosclerosis 1991; 86: 173–81
   PubMedGoogle Scholar
• Wang X. Z., Wilcken D. E., Dudman N. P. Early expression of the apolipoprotein (a) gene: relationships between infants and their parent serum apolipoprotein (a) levels. Pediatrics 1992; 89: 401–6
   PubMed Web of Science ®Google Scholar
• Wang X. L., Wilcken D. E., Dudman N. P. Neonatal apo A‐I, apo B and apo(a) levels in dried blood spots in an Australian population. Pediatr Res 1990; 28: 496–501
   PubMedGoogle Scholar
• Levitsky L., Scanu A. M., Gould S. Lipoprotein (a) levels in black and white children and adolescents with IDDM. Diabetes Care 1991; 14: 283–7
   PubMedGoogle Scholar
• Srinivasan S. R., Dahlen G. H., Jarpa R. A., Webber L. S., Berenson G. S. Racial (black–white) differences in serum lipoprotein(a) distribution and its relation to parental myocardial infarction in children. Bogalusa Heart Study. Circulation 1991; 84: 160–7
   PubMed Web of Science ®Google Scholar
• Bao W., Srinivasan S. R., Berenson G. S. Tracking of serum apolipoproteins A‐I and B in children and young adults: the Bogalusa Heart Study. J Clin Epidemiol 1993; 46: 609–16
   PubMedGoogle Scholar
• Webber L. S., Srinivasan S. R., Voors A. W., Berenson G. S. Persistence of levels for risk factor variable during the first year of life. The Bogalusa Heart Study. J Chron Dis 1980; 33: 157–67
   PubMedGoogle Scholar
• Fosoati P., Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produced hydrogen peroxide. Clin Chem 1982; 28: 2077–9
   PubMedGoogle Scholar
• Freedman D. S., Byers T., Sell K., Kuester S., Nevell E., Lee S. Tracking of serum cholesterol levels in a multiracial sample of preschool children. Pediatrics 1992; 90: 80–6
   PubMed Web of Science ®Google Scholar
• Sanchez‐Bayle M., Gonzalez‐Requejo A., Ruiz‐Jarabo C., Asensio J., Boeza S., Vila S., et al. Serum lipids and apolipoproteins in Spanish children and adolescents: a 5‐year follow‐up. Acta Paediatr 1996; 85: 292–4
   PubMedGoogle Scholar
• Steinmetz A., Thiemann E., Czekelius P., Kaffarnik H. Polymorphism of apolipoprotein E influences levels of serum apolipoproteins E and B in the human neonate. Eur J Clin Invest 1989; 19: 390–4
   PubMedGoogle Scholar
• Cameron M. E., Van Staveren W. A., editors. Manual on methodology for food consumption studies. Oxford University Press, OxfordUK 1988
   Google Scholar
• Lehtimäki T., Moilanen T., Viikari J., Akerblom K., Ehnholm C., Rönnemaa T., et al. Apolipoprotein E phenotypes in Finnish youth: a cross‐sectional and 6‐year follow‐up study. J Lipid Res 1990; 31: 487–95
   PubMed Web of Science ®Google Scholar
• Eto M., Watanabe K., Ishii K. Reciprocal effects of apolipoprotein E alleles on plasma lipid levels in normolipidemic subjects. Clin Genet 1986; 29: 477–84
   PubMed Web of Science ®Google Scholar
• Utermann G. Apolipoprotein E polymorphism in health and disease. Am Heart J 1987; 113: 433–40
   PubMed Web of Science ®Google Scholar
• Weintraub M. S., Eisenberg S., Breslow J. L. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 1987; 80: 1571–7
   PubMedGoogle Scholar
• Herrmann W., Hanf S., Kaffarnik H., Motzny S., Reissner J., Steinmetz A. The influence of apolipoprotein E polymorphism on plasma concentrations of apolipoprotein B and A‐I during the first year of life. Pediatrics 1994; 93: 296–302
   PubMedGoogle Scholar
• Lehtimäki T., Porkka K., Viikari J., Ehnholm C., Akerblom H., Nikkari T. Apolipoprotein E phenotypes and serum lipids in newborns and 3‐year‐old children: the cardiovascular risk in the Young Finns Study. Pediatrics 1994; 94: 489–93
   PubMedGoogle Scholar
• Routi T., Rönnemaa T., Salo P., Seppänen R., Marniemi J., Viikari J., et al. Effects of prospective, randomized cholesterol‐lowering dietary intervention and lipoprotein E phenotype on serum lipoprotein (a) concentrations of infants aged 7–24 mo. Am J Clin Nutr 1996; 63: 386–91
   PubMed Web of Science ®Google Scholar
• Srinivasan S. R., Ehnholm C., Elkasabany A., Berenson G. Influence of apolipoprotein E polymorphism on serum lipids and lipoprotein changes from childhood to adulthood. The Bogalusa Heart Study. Atherosclerosis 1999; 143: 435–43
   PubMed Web of Science ®Google Scholar
• Gueguen R., Visvikis S., Steinmetz J., Siest G., Boerwinkle E. Analysis of genotype effects and their interactions using the apolipoprotein E polymorphism and longitudinal data. Am J Hum Genet 1989; 45: 793
   PubMed Web of Science ®Google Scholar
• Barker D. J. B., editor. Fetal and infant origins of adult disease. BMJ Publishing Group, London 1992
   Google Scholar